Analyze Diet
Nature genetics2008; 40(8); 1004-1009; doi: 10.1038/ng.185

A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse.

Abstract: In horses, graying with age is an autosomal dominant trait associated with a high incidence of melanoma and vitiligo-like depigmentation. Here we show that the Gray phenotype is caused by a 4.6-kb duplication in intron 6 of STX17 (syntaxin-17) that constitutes a cis-acting regulatory mutation. Both STX17 and the neighboring NR4A3 gene are overexpressed in melanomas from Gray horses. Gray horses carrying a loss-of-function mutation in ASIP (agouti signaling protein) had a higher incidence of melanoma, implying that increased melanocortin-1 receptor signaling promotes melanoma development in Gray horses. The Gray horse provides a notable example of how humans have cherry-picked mutations with favorable phenotypic effects in domestic animals.
Publication Date: 2008-07-20 PubMed ID: 18641652DOI: 10.1038/ng.185Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research explores how a specific mutation in horses causes them to gray prematurely and become more susceptible to melanoma, a type of skin cancer. The study further examines the relationship between this mutation and the increased risk of melanoma in horses carrying it.

Study Objective and Findings

  • This research aimed to elucidate the genetic factors underlying premature graying in horses, as well as the seeming link between this graying and an elevated risk of melanoma.
  • The Gray phenotype in horses, associated with premature graying, vitiligo-like depigmentation, and a high incidence of melanoma, was found to be caused by a 4.6-kb duplication in intron 6 of the STX17 (syntaxin-17) gene.
  • This duplication is a type of cis-regulatory mutation, meaning it’s a mutation in a sequence of DNA that regulates the transcription of a gene.

Gene Overexpression and its Implications

  • The researchers noticed that both the STX17 gene and the neighbouring NR4A3 gene were overexpressed in melanomas from Gray horses.
  • Overexpression refers to a scenario where a gene is more active than it would typically be, leading to the production of more of the associated protein than normal.
  • This overexpression in the context of premature graying suggests a link between these genes and the higher incidence of melanoma.

Interplay of Genetic Factors

  • The study found that Gray horses carrying a loss-of-function mutation in ASIP (agouti signalling peptide) had a higher incidence of melanoma.
  • A loss-of-function mutation in a gene causes that gene to produce a non-functional protein, possibly disrupting normal body functions.
  • This finding suggests that increased melanocortin-1 receptor signalling, brought about by the malfunctioning ASIP, promotes melanoma development in Gray horses.

Human Impact and Genetic Selection

  • The study’s conclusion reinforces that the Gray phenotype in horses is an example of how humans have historically selected for mutations with perceived positive effects in domesticated animals, in this case, a distinctive coat color.
  • This human-driven genetic selection, while resulting in desirable traits, can also inadvertently lead to increased disease susceptibility, as observed with the increased melanoma risk in Gray horses.

Cite This Article

APA
Rosengren Pielberg G, Golovko A, Sundström E, Curik I, Lennartsson J, Seltenhammer MH, Druml T, Binns M, Fitzsimmons C, Lindgren G, Sandberg K, Baumung R, Vetterlein M, Strömberg S, Grabherr M, Wade C, Lindblad-Toh K, Pontén F, Heldin CH, Sölkner J, Andersson L. (2008). A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Nat Genet, 40(8), 1004-1009. https://doi.org/10.1038/ng.185

Publication

ISSN: 1546-1718
NlmUniqueID: 9216904
Country: United States
Language: English
Volume: 40
Issue: 8
Pages: 1004-1009

Researcher Affiliations

Rosengren Pielberg, Gerli
  • Department of Medical Biochemistry and Microbiology, Uppsala University, Box 597, SE-751 24 Uppsala, Sweden.
Golovko, Anna
    Sundström, Elisabeth
      Curik, Ino
        Lennartsson, Johan
          Seltenhammer, Monika H
            Druml, Thomas
              Binns, Matthew
                Fitzsimmons, Carolyn
                  Lindgren, Gabriella
                    Sandberg, Kaj
                      Baumung, Roswitha
                        Vetterlein, Monika
                          Strömberg, Sara
                            Grabherr, Manfred
                              Wade, Claire
                                Lindblad-Toh, Kerstin
                                  Pontén, Fredrik
                                    Heldin, Carl-Henrik
                                      Sölkner, Johann
                                        Andersson, Leif

                                          MeSH Terms

                                          • Animals
                                          • Cell Line, Tumor
                                          • Gene Duplication
                                          • Genetic Predisposition to Disease
                                          • Hair Color / genetics
                                          • Horses
                                          • Humans
                                          • Melanoma / genetics
                                          • Melanoma / metabolism
                                          • Mice
                                          • Molecular Sequence Data
                                          • Qa-SNARE Proteins / genetics
                                          • Qa-SNARE Proteins / metabolism
                                          • Receptor, Melanocortin, Type 1 / metabolism
                                          • Receptors, Cytoplasmic and Nuclear / genetics
                                          • Receptors, Cytoplasmic and Nuclear / metabolism
                                          • Selection, Genetic